Hideaki Tahara

8PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyBiologically active moleculesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 09, 2024
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8.

Yu Mizote, Takako Inoue, Takashi Akazawa

|Sep 26, 2022
GSTA4 Governs Melanoma Immune Resistance and Metastasis.

Sisca Ucche, Satoru Yokoyama, Marija Mojic

|Jun 29, 2021
NKG2D defines tumor-reacting effector CD8+ T cells within tumor microenvironment.

Marija Mojic, Kiyomi Shitaoka, Chikako Ohshima

|Feb 10, 2021
ASK1 suppresses NK cell-mediated intravascular tumor cell clearance in lung metastasis.

Makoto Fujimoto, Miki Kamiyama, Kosuke Fuse

|Jun 24, 2020
Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells.

Kiho Miyazato, Hideaki Tahara, Yoshihiro Hayakawa

|Aug 30, 2018
Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy.

Takashi Kanemura, Hiroshi Miyata, Tomoki Makino

Pageof 2